Specified Clinical Research Contract concluded with Edogawa Hospital
― Providing our drug for Research on FDG-PET-positive shallow tumors ― Stell……
― Providing our drug for Research on FDG-PET-positive shallow tumors ― Stell……
We would like to announce that our company submitted the trial plan notificatio……
Together with China Biotech Services Holdings Limited (CBSH), our partner for t……
Our company provides Steboronine® for the investigator-initiated specified clin……
The international science journal “Nature” published in its special edition “Ra……
Our company provides the boron drug for BNCT (Boron Neutron Capture Therapy), w……
The results regarding safety and effectiveness of our product Borofalan(10B), u……
We would like to announce that Phase I clinical trial for newly diagnosed gliob……
Stella Pharma Corporation , Mitsubishi Chemical Corporation of the Mitsubishi C……
Sumitomo Heavy Industries, Ltd. and STELLA PHARMA CORPORATION have respectively……
STELLA PHARMA CORPORATION (Head office: Chuoku, Osaka City; President: Tomoyuki……
STELLA PHARMA CORPORATION (Head office: Chuo-ku, Osaka City, President: Tomoyuk……